News | News By Subject | News by Disease News By Date | Search News

Crohn's disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Gilead (GILD) Looking Even Weaker on the R&D Front as It Racks Up Some More Clinical Failures in Q3 Report     11/2/2016
What You May Have Missed: Critics Point to Problems With Celgene (CELG)’s Crohn’s Drug Trial Design     10/20/2016
TiGenix Lands $400 Million+ Crohn's Disease Deal with Pharma Giant Takeda (TKPYY)     7/6/2016
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
AbbVie (ABBV) Coughs Up $595 Million+ for Boehringer Ingelheim's Psoriasis and Crohn’s Drugs     3/8/2016
Galapagos (GLPG.BR) Crohn’s Trial Data Might Make it An Attractive M&A Target for Amgen (AMGN)     12/9/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
TiGenix's Cx601 Meets Primary Endpoint in Phase III Study     8/31/2015
AstraZeneca PLC (AZN) Offloads Crohn's Disease Drug for $215 Million     7/10/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
J.P. Morgan: Celgene (CELG) to Fast-Track Crohn's Drug, Provides Estimates Up to 2020     1/13/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts     10/21/2014
Celgene Corporation (CELG) Antes Up $710 Million Upfront For Phase 3-Ready Crohn's Disease Drug     4/24/2014

News from Around the Web
Mothers Can Pass Traits To Offspring Through Bacteria's DNA, Washington University in St. Louis Study     2/23/2015
Could Gut Bacteria That Help Us Digest Beer & Bread Fight Disease, Too? University of Michigan Medical School Study     1/8/2015
Genetically Engineered Bacteria Could Help in Crohn's and Colitis, Centre de Physiopathologie de Toulouse-Purpan Study     11/2/2012
Potential New Drug Therapy for Crohn's Disease, University of California, San Diego (UCSD) Study     10/18/2012
Discovery Finds Cancer Drugs Offer New Hope for Crohn's Disease and Sarcoidosis, Case Western Reserve University Study     12/1/2010
Adding Immunomodulating Agents and Corticosteroids to Adalimumab Increases Risks of Infection for Patients With Crohn's Disease, Mayo Clinic Study Presented at American College of Gastroenterology     10/22/2010
American College of Gastroenterology: Acute IBD Flares Respond to Infliximab, University of Pittsburgh Study     10/20/2010
American College of Gastroenterology: Upfront Biologics Improve Crohn's Outcomes, State University of New York at Buffalo Study     10/19/2010
Broccoli, Plantains May Stop Crohn's Disease Relapse, University of Liverpool and Collaborators Study     8/26/2010
Prebiotics Won't Relieve Crohn's, According to Research Presented at Digestive Disease Week     5/7/2010
Better Treatment Found for Crohn's Disease, Mayo Clinic Study     4/15/2010
Genetic Variants Associated With a Risk of Crohn's Disease, University of Copenhagen Study     4/7/2010
Gene Discovery Gives Clues to Crohn's Disease, Colitis, University College London Study     11/5/2009
UK Scientists Say They've Found A Cure For Crohn's, University of Nottingham Study     6/26/2009
Probiotic May Help Treat Crohn's Disease, Institut National de Recherche Agronomique Study     10/21/2008

Press Releases
Janssen Biotech (JNJ) Release: New Data Shows STELARA (ustekinumab) Maintained Clinical Response And Remission After Two Years Of Treatment In Adult Patients With Moderately To Severely Active Crohn's Disease     2/17/2017
Viriom Reports Positive Findings In Phase IIb Study Of Elpida As Compared To Efavirenz In Combination With TDF/FTC At CROI 2017     2/17/2017
Pfizer (PFE) Release: New Data In Crohn’s Disease Patients Shows Similar Efficacy And Safety Profiles For INFLECTRA And REMICADE     2/17/2017
Celltrion Healthcare (068270.KQ) Releases Positive Results From Pivotal Study In Crohn’s Disease     2/17/2017
Takeda (TKPYY) And TiGenix Report New Data Highlighting Maintenance Of Long-Term Remission Of Complex Perianal Fistulas In Crohn’s Disease Patients With Cx601     2/17/2017
Theravance Biopharma (TBPH) Presents Positive Clinical Data On TD-1473 At The 12th Congress Of The European Crohn's And Colitis Organization     2/17/2017
Protagonist (PTGX) Presents Data On Oral Peptide Drug Candidates At European Crohn's And Colitis Organization (ECCO) Congress     2/17/2017
Enterome Starts Phase I Clinical Trial With Its Lead Candidate EB8018 To Treat Crohn's Disease     1/5/2017
Janssen Release: Health Canada Approves STELARA For The Treatment Of Adults With Moderately To Severely Active Crohn's Disease     12/14/2016
Tillotts Pharma AG's Parent Company Zeria Pharmaceutical Co., Ltd. Launches Zentacort 3mg Capsules In Japan For Treatment In Crohn's Disease     12/14/2016
RedHill Biopharma (RDHL) Announces Positive And Unanimous DSMB Recommendation For Continuation Of Phase III Study With RHB-104 For Crohn's Disease     12/13/2016
Celltrion Healthcare (068270.KQ) Release: New Statement From European Crohn's And Colitis Organisation Supports Switching To Biosimilar From Reference Product In Inflammatory Bowel Disease     12/9/2016
AbbVie (ABBV) Receives Orphan Drug Designation For Investigational IL-23 Inhibitor Risankizumab From The U.S. FDA For The Treatment Of Pediatric Patients With Crohn's Disease     12/1/2016
Takeda (TKPYY) Release: New Treatment For Ulcerative Colitis And Crohn’s Disease Launched In UAE     11/29/2016
Janssen Pharmaceutical Companies Release: Phase 3 Study Results Supporting U.S. FDA And European Commission (EC) Approvals Of STELARA In The Treatment Of Moderately To Severely Active Crohn's Disease Published In The New England Journal of Medicine     11/17/2016

//-->